Several other brokerages have also recently weighed in on CERN. Zacks Investment Research cut shares of Cerner from a buy rating to a hold rating in a research report on Thursday, January 4th. Cantor Fitzgerald reaffirmed a buy rating and issued a $80.00 target price on shares of Cerner in a research report on Wednesday, March 14th. BidaskClub cut shares of Cerner from a hold rating to a sell rating in a research report on Wednesday, January 24th. Evercore ISI started coverage on shares of Cerner in a research report on Thursday, January 18th. They issued an in-line rating and a $77.00 target price for the company. Finally, Royal Bank of Canada reaffirmed a buy rating and issued a $76.00 target price on shares of Cerner in a research report on Wednesday, February 7th. One analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has an average rating of Hold and a consensus target price of $67.87.
Shares of CERN opened at $58.00 on Thursday. The firm has a market cap of $19,290.63, a price-to-earnings ratio of 26.36, a PEG ratio of 1.69 and a beta of 0.93. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.01 and a quick ratio of 2.99. Cerner has a twelve month low of $56.49 and a twelve month high of $73.86.
In related news, Director William D. Zollars sold 4,100 shares of Cerner stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $62.16, for a total transaction of $254,856.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman Clifford W. Illig sold 307,700 shares of Cerner stock in a transaction dated Thursday, March 8th. The shares were sold at an average price of $64.52, for a total transaction of $19,852,804.00. Following the transaction, the insider now directly owns 1,229,719 shares of the company’s stock, valued at $79,341,469.88. The disclosure for this sale can be found here. Over the last three months, insiders have sold 541,800 shares of company stock valued at $34,353,860. 13.11% of the stock is currently owned by corporate insiders.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Icon Wealth Partners LLC purchased a new position in Cerner during the 4th quarter valued at about $107,000. Cerebellum GP LLC purchased a new position in Cerner during the 4th quarter valued at about $127,000. Steward Partners Investment Advisory LLC purchased a new position in Cerner during the 3rd quarter valued at about $128,000. Delpha Capital Management LLC purchased a new position in Cerner during the 4th quarter valued at about $144,000. Finally, Virtue Capital Management LLC purchased a new position in Cerner during the 4th quarter valued at about $197,000. 78.54% of the stock is owned by institutional investors.
Cerner Corporation provides health care information technology solutions and services in the United States and internationally. The company offers Cerner Millennium architecture, a person-centric computing framework, which includes clinical, financial, and management information systems that allow providers to access an individual's electronic health record (EHR) at the point of care, and organizes and delivers information for physicians, nurses, laboratory technicians, pharmacists, front- and back-office professionals, and consumers.
Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.